Fmr LLC Lyell Immunopharma, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,733,462 shares of LYEL stock, worth $4.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,733,462

Previous 2,769,262 1.29%

Holding current value

$4.26 Million

Previous $6.18 Million 35.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.3 - $3.01 $46,540 - $107,757	-35,800 Reduced 1.29%	2,733,462 $3.96 Million
Q1 2024 May 13, 2024	SELL	$1.71 - $3.07 $33,285 - $59,757	-19,465 Reduced 0.7%	2,769,262 $6.18 Million
Q4 2023 Feb 13, 2024	SELL	$1.39 - $2.35 $81,591 - $137,942	-58,699 Reduced 2.06%	2,788,727 $5.41 Million
Q3 2023 Nov 13, 2023	SELL	$1.45 - $3.35 $24,681 - $57,023	-17,022 Reduced 0.59%	2,847,426 $4.19 Million
Q2 2023 Aug 11, 2023	SELL	$1.89 - $3.86 $124,280 - $253,822	-65,757 Reduced 2.24%	2,864,448 $9.11 Million
Q1 2023 May 11, 2023	SELL	$1.97 - $3.58 $81,097 - $147,374	-41,166 Reduced 1.39%	2,930,205 $6.92 Million
Q4 2022 Feb 13, 2023	SELL	$2.78 - $8.09 $898,657 - $2.62 Million	-323,258 Reduced 9.81%	2,971,371 $10.3 Million
Q3 2022 Nov 10, 2022	BUY	$5.54 - $8.27 $2.73 Million - $4.08 Million	493,098 Added 17.6%	3,294,629 $24.2 Million
Q2 2022 Aug 12, 2022	BUY	$3.68 - $6.8 $1.17 Million - $2.17 Million	319,208 Added 12.86%	2,801,531 $18.3 Million
Q1 2022 May 13, 2022	BUY	$5.05 - $7.7 $7.17 Million - $10.9 Million	1,419,870 Added 133.64%	2,482,323 $12.5 Million
Q4 2021 Feb 14, 2022	BUY	$7.13 - $15.19 $4.87 Million - $10.4 Million	683,153 Added 180.11%	1,062,453 $8.22 Million
Q3 2021 Nov 15, 2021	BUY	$11.0 - $17.95 $1.45 Million - $2.37 Million	132,100 Added 53.44%	379,300 $5.61 Million
Q2 2021 Aug 13, 2021	BUY	$15.99 - $16.89 $3.95 Million - $4.18 Million	247,200 New	247,200 $4.01 Million

Others Institutions Holding LYEL

# of Institutions

123

Shares Held

145M

Call Options Held

2.6K

Put Options Held

7.5K

View Full List

About Lyell Immunopharma, Inc.

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $387M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

More about LYEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account